SlideShare a Scribd company logo
1 of 28
Download to read offline
1
Integration of HIV Testing Within
Routine Care in a Large Public Hospital
System
Joanna Omi
Senior Assistant Vice President
Corporate Planning and HIV Services
New York City Health and Hospitals Corporation
New York, NY
November 6, 2007
Copyright 2007, Joanna Omi, Joanna.Omi@nychhc.org
2
Topics covered
• Overview of HIV and the HIV Testing
Expansion Initiative
• Corporatewide and facility results
• Lessons learned
Copyright 2007, Joanna Omi, Joanna.Omi@nychhc.org
3
8.2 million people
live in NYC
100,000 of these are
HIV positive and
25,000 do
not
know it
(est.)
HHC serves 1.3 million
New Yorkers each year
It can be extrapolated that
each year approximately 4,000
undiagnosed HIV positive
New Yorkers access services
at an HHC facility
HHC is in the epicenter of the national
HIV/AIDS epidemic
Copyright 2007, Joanna Omi, Joanna.Omi@nychhc.org
4
New York City Health and Hospitals
Corporation (HHC)
• Public benefit corporation created in 1969
• Largest municipal healthcare delivery system in US
– 11 acute care hospitals with State Designated AIDS
Centers
– 6 diagnostic and treatment centers (D&TCs)
– 4 long-term care hospitals
– 95 extension clinics
– MetroPlus (health maintenance organization)
– Partnership in Care (HIV-specific managed care plan)
– Home care agency
Copyright 2007, Joanna Omi, Joanna.Omi@nychhc.org
5
HHC, continued
• 1.3 million New Yorkers served
• 224,300 discharges
• 4,934,600 visits
• $5.5B operating budget
• Approximately 19,000 patients with
HIV/AIDS
Note: FY07 Data
Copyright 2007, Joanna Omi, Joanna.Omi@nychhc.org
6
Copyright 2007, Joanna Omi, Joanna.Omi@nychhc.org
7
HIV Testing Expansion Initiative:
Integrate HIV testing within routine medical care
• Increase the number of patients who know
their HIV status
• Test 150,000 unique patients (increased from 100,000
in FY06)
• Increase the proportion of patients who enter
care early
• Reduce the number of concurrent AIDS diagnoses
• Once in care, retain patients in care
• >80% of patients will have 2 medical visits in the last 12
months, with at least one visit in the last 6 months
Copyright 2007, Joanna Omi, Joanna.Omi@nychhc.org
8
HIV Testing Expansion Plan
Copyright 2007, Joanna Omi, Joanna.Omi@nychhc.org
9
The percentage of unique patients tested at
HHC hospitals steadily increased while
overall volume remained stable
FY05 outpatient and ED Pilot Sites Only (Source: PLM and Pilot Project Sites Reports)
FY06-FY07 outpatient, inpatient and ED (Source: PLM and Facility Reports)
3%
6%
7%
5%
7%
7%
5%
7%
10%
5%
4%
6%
5%
7%
9%
9%
9%
11%
11%
11%
10%
9%
7%
9%
8%
14%
13%
17%
12%
13%
15%
18%
15%
16%
8%
13%
0%
2%
4%
6%
8%
1 0%
1 2%
1 4%
1 6%
1 8%
2 0%
B ell C IH E lm H ar l Jac K C H L in c M e t N C B Q n s W o od A ll
A cu t es
%ofvolumetested
F Y 05 FY 0 6 F Y 07
Copyright 2007, Joanna Omi, Joanna.Omi@nychhc.org
10
The percentage of unique patients tested at
D&TCs steadily increased while overall
volume remained stable
FY05 outpatient and ED Pilot Sites Only (Source: PLM and Pilot Project Sites Reports)
FY06-FY07 outpatient, inpatient and ED (Source: PLM and Facility Reports)
14%
12%
10%
6%
10%
10%
9%
13%
11%
12%
7%
12%
19%
11%
28%
13%
16%
10%
17%
23%
16%
0%
5%
10%
15%
20%
25%
30%
B e lv C u m b E N Y G ou v M o rr R en A ll D & T C s
%ofvolumetested
FY 05 FY 0 6 F Y 07
Copyright 2007, Joanna Omi, Joanna.Omi@nychhc.org
11
9 2,12 3
62 ,023
13 3,8 59
0
30,0 00
60,0 00
90,0 00
1 20,0 00
1 50,0 00
F Y 05 F Y 06 F Y 07
Numberofuniquepatientstested
U n iq u e P re n ata l T e st s A ll O th e r U n iq u e T ests
The number of unique patients tested grew
while prenatal testing remained relatively
stable
FY05 All other unique tests outpatient and ED Pilot Sites Only (Source: PLM and Pilot Project Sites Reports)
FY06-FY07 All other unique tests outpatient, inpatient and ED (Source: Facility Reports)
FY05-FY07 Unique prenatal tests prenatal clinics only (Source: Siemens Data Warehouse)
45.3%
48.5%
Copyright 2007, Joanna Omi, Joanna.Omi@nychhc.org
12
Rapid HIV testing comprised the majority of
unique tests conducted in FY06 and FY07
FY05 outpatient and ED Pilot Sites Only (Source: PLM and Pilot Project Sites Reports)
FY06-FY07 outpatient, inpatient and ED (Source: Facility Reports)
0
5,000
10,000
15,000
20,000
25,000
30,000
35,000
40,000
Q1 Q 2 Q 3 Q 4 Q 1 Q2 Q 3 Q 4 Q 1 Q2 Q3 Q 4
NumberofUniquePatientsTested
C on vention al R H T
FY 05 FY 06 FY 0 7
Copyright 2007, Joanna Omi, Joanna.Omi@nychhc.org
13
But the use of rapid testing varied widely
across facilities
FY07 outpatient, inpatient and ED (Source: Facility Reports)
74%
100%
96%
99%
59%
100%
68%
100%
98%
35%
99%
90%
64%
99%
73%
95%
91%
26%
0%
4%
1%
41%
0%
32%
0%
2%
65%
1%
10%
36%
1%
27%
5%
9%
0%
20%
40%
60%
80%
100%
Bell Belv CIH Cumb Elm ENY Gouv Harl Jac KCH L inc M et M orr NC B Qns R enn Wood
%oftotaltestsbytechnology
RHT Conv
Copyright 2007, Joanna Omi, Joanna.Omi@nychhc.org
14
Patients in Care, Prevalence,
Incidence and Venues
Copyright 2007, Joanna Omi, Joanna.Omi@nychhc.org
15
People of color continue to represent the
largest percentage of unique HIV positive
patients in care…
FY06-FY07 All Venues (Source: PLM Database)
5%5 %
3 5%
53 %
1 %
5%4%
35%
54 %
1%
0
2,00 0
4,00 0
6,00 0
8,00 0
1 0,00 0
1 2,00 0
1 4,00 0
1 6,00 0
1 8,00 0
2 0,00 0
A S IA N B L A C K H IS P A N IC O T H E R W H IT E G r an d T ota l
HIVpatientsincarebyrace
FY 06 A ll V en u es FY 07 A ll V en u es
100 %10 0%
Copyright 2007, Joanna Omi, Joanna.Omi@nychhc.org
16
While men continue to represent the largest
number of unique HIV positive patients in
care
FY06-FY07 All Venues (Source: PLM Database)
6 1 %
3 9 %
6 1 %
3 9 %
0
2 ,0 0 0
4 ,0 0 0
6 ,0 0 0
8 ,0 0 0
1 0 ,0 0 0
1 2 ,0 0 0
1 4 ,0 0 0
1 6 ,0 0 0
1 8 ,0 0 0
2 0 ,0 0 0
F E M A L E M A L E G ra n d T o ta l
HIVpatientsincarebysex
F Y 0 6 A ll V en u es F Y 0 7 A ll V en u es
1 0 0 %1 0 0 %
Copyright 2007, Joanna Omi, Joanna.Omi@nychhc.org
17
Both the total number of unique patients who
tested HIV positive and the subgroup newly
diagnosed with HIV increased in FY07
FY06-FY07 outpatient, inpatient and ED (Source: Facility Reports)
1,514
774
1,630
8 64
0
20 0
40 0
60 0
80 0
1,00 0
1,20 0
1,40 0
1,60 0
1,80 0
All Pa tients w /HIV Po sitive R esults New ly Dia gnosed HIV Po sitiv e Pa tients
FY06 FY07
TotalHIVpositiveandnewlydiagnosed
8%
12%
Copyright 2007, Joanna Omi, Joanna.Omi@nychhc.org
18
Most networks focused their expansion efforts in
the outpatient and ED areas
FY07 outpatient, inpatient and ED (Source: Facility Reports)
87%
66%
74%
68%
54%
78%
71%
69%
9% 9%
4%
8% 7%
4%
12%
8%
4%
25%
21%
25%
39%
19% 18%
24%
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
C. Bkln Gen + N. Brx N. Bkln Qns S. Bkln S. Man. Corp.
%oftotaltestsbyvenue
Outpatient Inpatient ED
Copyright 2007, Joanna Omi, Joanna.Omi@nychhc.org
19
Across all networks, prevalence was highest
in inpatient units
FY07 outpatient, inpatient and ED (Source: Facility Reports)
1%
1%
1 %
2%
1%
0 %
2%
1%
6%
3%
6 %
4%
3%
4 %
5%
4%
4 %
1%
1%
1 %
1% 1%
2 %
1%
0 %
1 %
2 %
3 %
4 %
5 %
6 %
7 %
C. Bkln G en + N . Brx N. Bkln Qns S. Bkln S . M an. C orp.
HIVprevalencebyvenue
OP IP ED
Copyright 2007, Joanna Omi, Joanna.Omi@nychhc.org
20
As was the percentage of newly diagnosed HIV
positive patients
FY07 outpatient, inpatient and ED (Source: Facility Reports)
0 .6%
0.4 %
0.3%
0 .6%
0.4 %
0.3%
0 .6%
0.5 %
4 %
1%
3%
2 %
2%
4 %
2%
2%
2.2%
0 .9% 0.8 %
1.1%
0.4%
0.5 %
0 .9%
0.8%
0%
1%
2%
3%
4%
5%
C. Bkln G en + N . Brx N. Bkln Qns S. Bkln S . M an. C orp.
HIVPrevalencebyvenue
OP IP ED
Copyright 2007, Joanna Omi, Joanna.Omi@nychhc.org
21
Preliminary utilization data suggest the proportion of
newly HIV positive individuals may be greater in HHC
than in the city as a whole
FY07 outpatient, inpatient and ED (Source: Facility Reports)
NYC Incidence (Source: NYCDOHMH HIV Incidence Estimates Using STARHS – the serologic testing algorithm for recent
HIV seroconversions. CROI poster 2/2007)
NYC Prevalence (Source: NYC HIV/AIDS Annual Surveillance Statistics. 12/2006)
HHC Incidence
0.76%0.45%
2.02%
0%
1%
2%
3%
4%
Outpatient Inpatient ED
HHC Prevalence
3.78%
0.98% 1.08%
0%
1%
2%
3%
4%
Outpatient Inpatient ED
HHC Prevalence = 1.22%
NYC Prevalence=1.2%
HHC Incidence = .65%
NYC Incidence = .31%
Copyright 2007, Joanna Omi, Joanna.Omi@nychhc.org
22
Patients newly diagnosed with HIV in outpatient areas are
more likely to be scheduled for and keep their first HIV
primary care appointment
FY07 outpatient, inpatient and ED (Source: Facility Reports)
94 %
6 8%
85 % 86 %
90 %
77%
7 9%
84 %
0 %
20 %
40 %
60 %
80 %
1 00 %
O utpatie nt Inpa tien t ED To tal
%ofnewlydxpatientsscheduledandkeepingappointment
A p poin tm en t M a de A ppo intm e nt K e pt
Copyright 2007, Joanna Omi, Joanna.Omi@nychhc.org
23
Of patients newly diagnosed with HIV who kept their
first HIV appointment, fewer were concurrently
diagnosed with AIDS in FY07 vs. FY06
FY06-FY07 outpatient, inpatient and ED (Source: Facility Reports)
25 %
54 %
3 6%
32 %
1 6%
32 %
2 3%
21 %
0%
1 0%
2 0%
3 0%
4 0%
5 0%
6 0%
O u tp atie n t I n p a tien t E D T o tal
F Y 06 F Y 07
ProportionofNewHIVdxconcurrentlydxAIDSbyvenue
Copyright 2007, Joanna Omi, Joanna.Omi@nychhc.org
24
Accomplishments
• Large-scale implementation led to the identification of a
significant number of individuals who would not likely
otherwise have taken the opportunity to test.
• Rapid HIV testing is now available at all HHC acute care
hospitals and D&TCs (17 sites).
• All HHC acute care hospitals now offer HIV testing in
multiple venues: ED, inpatient units and at least three
outpatient clinics (including Dental, Medicine, Women’s
Health Services, Adolescent Health Services and Chemical
Dependency).
Copyright 2007, Joanna Omi, Joanna.Omi@nychhc.org
25
Variables that impact the expansion of
testing across HHC
Drivers
– Widespread use of a rapid, easy-to-use HIV test
– Consistent use of the streamlined HIV counseling model
with regular monitoring and evaluation
– Clinical and executive level commitment to expand testing
within the facilities
Inhibitors
– Number of clinicians offering and conducting testing at
some facilities
– Availability of interdisciplinary teams 24/7
– Dedicated space for counseling HIV-positive patients in all
venues
Copyright 2007, Joanna Omi, Joanna.Omi@nychhc.org
26
Data Caveats
• FY05 testing data represents outpatient and ED Pilot Sites
only.
• Data for FY06 and FY07 HIV-positive patients in care reflects
patients connected to care at the time of report and does not
capture patients who may have entered care at a later date.
• The number of unique patients tested for HIV is based on
patient self-report and facility medical records.
• Identification of ‘new diagnosis’ is based on patient self-report
and facility medical records.
• Medical records are unique to each facility and in some cases,
networks. It is possible in some instances that counts are not
unduplicated between sites.
Copyright 2007, Joanna Omi, Joanna.Omi@nychhc.org
27
Summary messages
• Encouraging patients to know their HIV status is a
message that resonates with health care professionals.
• The presence of clinician champions and well
functioning, interdisciplinary teams can significantly
improve testing rates.
• Inpatient testing provides significant opportunities as well
as challenges in complex teaching facilities.
• Best practices for successful expansion of HIV testing
will look different at each facility – one size does not fit
all.
• HHC - facilities and centrally - will continue to examine
the data being generated to inform long-term direction
and other service and policy implications.
Copyright 2007, Joanna Omi, Joanna.Omi@nychhc.org
28
Acknowledgements and Appreciation
Terry Hamilton, Director of HIV Services, HHC
Drew De Los Reyes, Senior Management Consultant, HHC
Jay Gabor, Senior Management Consultant, HHC
Judy Aberg, MD, Medical Director of HIV Services, Bellevue
Hospital Center and the HHC South Manhattan Network
The dedicated physicians, nurses, administrators,
patient care associates, HIV counselors,
phlebotomists, lab directors and many others
throughout HHC who have contributed to the HIV
testing expansion effort
Copyright 2007, Joanna Omi, Joanna.Omi@nychhc.org

More Related Content

What's hot

IAS 2015.8th IAS Conference on HIV Pathogenesis, Treatment and Prevention
IAS 2015.8th IAS Conference on HIV Pathogenesis, Treatment and PreventionIAS 2015.8th IAS Conference on HIV Pathogenesis, Treatment and Prevention
IAS 2015.8th IAS Conference on HIV Pathogenesis, Treatment and Preventionhivlifeinfo
 
Rx15 tpp tues_330_1_gavin_2nader_3jeter
Rx15 tpp tues_330_1_gavin_2nader_3jeterRx15 tpp tues_330_1_gavin_2nader_3jeter
Rx15 tpp tues_330_1_gavin_2nader_3jeterOPUNITE
 
Pulmonary Embolism: Next Generation
Pulmonary Embolism: Next GenerationPulmonary Embolism: Next Generation
Pulmonary Embolism: Next GenerationCoda Change
 
20160119 디지털 헬스케어 의사모임 1월 전체 파일 v3
20160119 디지털 헬스케어 의사모임 1월 전체 파일 v320160119 디지털 헬스케어 의사모임 1월 전체 파일 v3
20160119 디지털 헬스케어 의사모임 1월 전체 파일 v3Chiweon Kim
 
Νικόλαος Τσούλος, MedTech Conference 2021
Νικόλαος Τσούλος, MedTech Conference 2021Νικόλαος Τσούλος, MedTech Conference 2021
Νικόλαος Τσούλος, MedTech Conference 2021Starttech Ventures
 
Should Integrase Inhibitors Be Your First Choice When Starting HIV Therapy- E...
Should Integrase Inhibitors Be Your First Choice When Starting HIV Therapy- E...Should Integrase Inhibitors Be Your First Choice When Starting HIV Therapy- E...
Should Integrase Inhibitors Be Your First Choice When Starting HIV Therapy- E...Hivlife Info
 
Using Data to Improve Linkage to Care
Using Data to Improve Linkage to CareUsing Data to Improve Linkage to Care
Using Data to Improve Linkage to CareRandi Sylve
 
SPOTLIGHT ON THE PREMIUM CHANNEL
SPOTLIGHT ON THE PREMIUM CHANNELSPOTLIGHT ON THE PREMIUM CHANNEL
SPOTLIGHT ON THE PREMIUM CHANNELHealthegy
 
Antiretroviral Therapy Update 2016
Antiretroviral Therapy Update 2016Antiretroviral Therapy Update 2016
Antiretroviral Therapy Update 2016hivlifeinfo
 
IPOS10 T680 - Implementation of a Screening Programme for Cancer Related Dist...
IPOS10 T680 - Implementation of a Screening Programme for Cancer Related Dist...IPOS10 T680 - Implementation of a Screening Programme for Cancer Related Dist...
IPOS10 T680 - Implementation of a Screening Programme for Cancer Related Dist...Alex J Mitchell
 
Disparities in Patient Safety - Presentation from 2013 Maryland Patient Safet...
Disparities in Patient Safety - Presentation from 2013 Maryland Patient Safet...Disparities in Patient Safety - Presentation from 2013 Maryland Patient Safet...
Disparities in Patient Safety - Presentation from 2013 Maryland Patient Safet...Noel Eldridge
 
BioSHaRE: Risk stratification using genomic and lifestyle information - Samul...
BioSHaRE: Risk stratification using genomic and lifestyle information - Samul...BioSHaRE: Risk stratification using genomic and lifestyle information - Samul...
BioSHaRE: Risk stratification using genomic and lifestyle information - Samul...Lisette Giepmans
 
Модификация схем АРТ у пациентов с вирусной супрессией и после вирусологичес...
Модификация схем АРТ у пациентов с  вирусной супрессией и после вирусологичес...Модификация схем АРТ у пациентов с  вирусной супрессией и после вирусологичес...
Модификация схем АРТ у пациентов с вирусной супрессией и после вирусологичес...hivlifeinfo
 
Improved Performance of the Malaria Surveillance, Monitoring, and Evaluation ...
Improved Performance of the Malaria Surveillance, Monitoring, and Evaluation ...Improved Performance of the Malaria Surveillance, Monitoring, and Evaluation ...
Improved Performance of the Malaria Surveillance, Monitoring, and Evaluation ...MEASURE Evaluation
 
Final ppahs notre dame presentation
Final ppahs notre dame presentationFinal ppahs notre dame presentation
Final ppahs notre dame presentationMike Wong
 
Dr. Jason Ross - Improving Sow Survivability
Dr. Jason Ross - Improving Sow SurvivabilityDr. Jason Ross - Improving Sow Survivability
Dr. Jason Ross - Improving Sow SurvivabilityJohn Blue
 

What's hot (20)

IAS 2015.8th IAS Conference on HIV Pathogenesis, Treatment and Prevention
IAS 2015.8th IAS Conference on HIV Pathogenesis, Treatment and PreventionIAS 2015.8th IAS Conference on HIV Pathogenesis, Treatment and Prevention
IAS 2015.8th IAS Conference on HIV Pathogenesis, Treatment and Prevention
 
ClearView Orphan Drug White Paper
ClearView Orphan Drug White PaperClearView Orphan Drug White Paper
ClearView Orphan Drug White Paper
 
Rx15 tpp tues_330_1_gavin_2nader_3jeter
Rx15 tpp tues_330_1_gavin_2nader_3jeterRx15 tpp tues_330_1_gavin_2nader_3jeter
Rx15 tpp tues_330_1_gavin_2nader_3jeter
 
Pulmonary Embolism: Next Generation
Pulmonary Embolism: Next GenerationPulmonary Embolism: Next Generation
Pulmonary Embolism: Next Generation
 
20160119 디지털 헬스케어 의사모임 1월 전체 파일 v3
20160119 디지털 헬스케어 의사모임 1월 전체 파일 v320160119 디지털 헬스케어 의사모임 1월 전체 파일 v3
20160119 디지털 헬스케어 의사모임 1월 전체 파일 v3
 
Νικόλαος Τσούλος, MedTech Conference 2021
Νικόλαος Τσούλος, MedTech Conference 2021Νικόλαος Τσούλος, MedTech Conference 2021
Νικόλαος Τσούλος, MedTech Conference 2021
 
Should Integrase Inhibitors Be Your First Choice When Starting HIV Therapy- E...
Should Integrase Inhibitors Be Your First Choice When Starting HIV Therapy- E...Should Integrase Inhibitors Be Your First Choice When Starting HIV Therapy- E...
Should Integrase Inhibitors Be Your First Choice When Starting HIV Therapy- E...
 
Using Data to Improve Linkage to Care
Using Data to Improve Linkage to CareUsing Data to Improve Linkage to Care
Using Data to Improve Linkage to Care
 
SPOTLIGHT ON THE PREMIUM CHANNEL
SPOTLIGHT ON THE PREMIUM CHANNELSPOTLIGHT ON THE PREMIUM CHANNEL
SPOTLIGHT ON THE PREMIUM CHANNEL
 
Antiretroviral Therapy Update 2016
Antiretroviral Therapy Update 2016Antiretroviral Therapy Update 2016
Antiretroviral Therapy Update 2016
 
IPOS10 T680 - Implementation of a Screening Programme for Cancer Related Dist...
IPOS10 T680 - Implementation of a Screening Programme for Cancer Related Dist...IPOS10 T680 - Implementation of a Screening Programme for Cancer Related Dist...
IPOS10 T680 - Implementation of a Screening Programme for Cancer Related Dist...
 
Disparities in Patient Safety - Presentation from 2013 Maryland Patient Safet...
Disparities in Patient Safety - Presentation from 2013 Maryland Patient Safet...Disparities in Patient Safety - Presentation from 2013 Maryland Patient Safet...
Disparities in Patient Safety - Presentation from 2013 Maryland Patient Safet...
 
Final Report
Final ReportFinal Report
Final Report
 
BioSHaRE: Risk stratification using genomic and lifestyle information - Samul...
BioSHaRE: Risk stratification using genomic and lifestyle information - Samul...BioSHaRE: Risk stratification using genomic and lifestyle information - Samul...
BioSHaRE: Risk stratification using genomic and lifestyle information - Samul...
 
Модификация схем АРТ у пациентов с вирусной супрессией и после вирусологичес...
Модификация схем АРТ у пациентов с  вирусной супрессией и после вирусологичес...Модификация схем АРТ у пациентов с  вирусной супрессией и после вирусологичес...
Модификация схем АРТ у пациентов с вирусной супрессией и после вирусологичес...
 
Improved Performance of the Malaria Surveillance, Monitoring, and Evaluation ...
Improved Performance of the Malaria Surveillance, Monitoring, and Evaluation ...Improved Performance of the Malaria Surveillance, Monitoring, and Evaluation ...
Improved Performance of the Malaria Surveillance, Monitoring, and Evaluation ...
 
Canadian VTE Audit - Information Call
Canadian VTE Audit - Information CallCanadian VTE Audit - Information Call
Canadian VTE Audit - Information Call
 
Final ppahs notre dame presentation
Final ppahs notre dame presentationFinal ppahs notre dame presentation
Final ppahs notre dame presentation
 
Dr. Jason Ross - Improving Sow Survivability
Dr. Jason Ross - Improving Sow SurvivabilityDr. Jason Ross - Improving Sow Survivability
Dr. Jason Ross - Improving Sow Survivability
 
Non-Medically Indicated Delivery Prior to 39 Weeks Gestation in United State...
Non-Medically Indicated Delivery Prior to 39 Weeks Gestation  in United State...Non-Medically Indicated Delivery Prior to 39 Weeks Gestation  in United State...
Non-Medically Indicated Delivery Prior to 39 Weeks Gestation in United State...
 

Similar to Integration of HIV Testing Within Routine Care in a Large Public Hospital System

Practicum Presentation
Practicum PresentationPracticum Presentation
Practicum Presentationguest231e1f
 
Kathleen Brady Philadelphia HIV Epidemiologic Update 2015
Kathleen Brady Philadelphia HIV Epidemiologic Update 2015Kathleen Brady Philadelphia HIV Epidemiologic Update 2015
Kathleen Brady Philadelphia HIV Epidemiologic Update 2015Office of HIV Planning
 
Leah Binder Presentation on Leapfrog Group on Maternity Care
Leah Binder Presentation on Leapfrog Group on Maternity CareLeah Binder Presentation on Leapfrog Group on Maternity Care
Leah Binder Presentation on Leapfrog Group on Maternity CareNational Coalition on Health Care
 
Leah Binder Presentation on Leapfrog Group on Maternity Care
Leah Binder Presentation on Leapfrog Group on Maternity CareLeah Binder Presentation on Leapfrog Group on Maternity Care
Leah Binder Presentation on Leapfrog Group on Maternity CareTherese Gratia
 
Mobile Health at Ochsner: The Apple HealthKit and Epic EMR Integration
Mobile Health at Ochsner: The Apple HealthKit and Epic EMR IntegrationMobile Health at Ochsner: The Apple HealthKit and Epic EMR Integration
Mobile Health at Ochsner: The Apple HealthKit and Epic EMR IntegrationRahlyn Gossen
 
Health2 150416154304-conversion-gate01
Health2 150416154304-conversion-gate01Health2 150416154304-conversion-gate01
Health2 150416154304-conversion-gate01Adam Rex
 
Presentation on the results to date of the Federal Partnership for Patients (...
Presentation on the results to date of the Federal Partnership for Patients (...Presentation on the results to date of the Federal Partnership for Patients (...
Presentation on the results to date of the Federal Partnership for Patients (...Noel Eldridge
 
Survillance and notification of communicable disease
Survillance and notification of communicable diseaseSurvillance and notification of communicable disease
Survillance and notification of communicable diseasemubeenButt5
 
Pharmacy Essentials for HIV Screening and Management.2019
Pharmacy Essentials for HIV Screening and Management.2019Pharmacy Essentials for HIV Screening and Management.2019
Pharmacy Essentials for HIV Screening and Management.2019hivlifeinfo
 
PICOTIn hospitalized medsurg patients , does med reconciliatio.docx
PICOTIn hospitalized medsurg patients , does med reconciliatio.docxPICOTIn hospitalized medsurg patients , does med reconciliatio.docx
PICOTIn hospitalized medsurg patients , does med reconciliatio.docxstilliegeorgiana
 
Hospital treated pneumonia - Diagnosis and Treatment
Hospital treated pneumonia - Diagnosis and TreatmentHospital treated pneumonia - Diagnosis and Treatment
Hospital treated pneumonia - Diagnosis and TreatmentBostonsp
 
Michael Ison - USA -Tuesday 29 - Donor Risk
Michael Ison  - USA -Tuesday 29 - Donor RiskMichael Ison  - USA -Tuesday 29 - Donor Risk
Michael Ison - USA -Tuesday 29 - Donor Riskincucai_isodp
 
Day 2: Danielle Rollmann, MIT FoCUS (Nov 19) Access to Innovation Conference ...
Day 2: Danielle Rollmann, MIT FoCUS (Nov 19) Access to Innovation Conference ...Day 2: Danielle Rollmann, MIT FoCUS (Nov 19) Access to Innovation Conference ...
Day 2: Danielle Rollmann, MIT FoCUS (Nov 19) Access to Innovation Conference ...Canadian Organization for Rare Disorders
 
Certified Nurse Leader (CNL) Capstone Project
Certified Nurse Leader (CNL) Capstone ProjectCertified Nurse Leader (CNL) Capstone Project
Certified Nurse Leader (CNL) Capstone Projectbdcw
 
Pediatric Adverse Drug Events Presentation
Pediatric Adverse Drug Events PresentationPediatric Adverse Drug Events Presentation
Pediatric Adverse Drug Events PresentationJordan Gamart
 

Similar to Integration of HIV Testing Within Routine Care in a Large Public Hospital System (20)

Practicum Presentation
Practicum PresentationPracticum Presentation
Practicum Presentation
 
Kathleen Brady Philadelphia HIV Epidemiologic Update 2015
Kathleen Brady Philadelphia HIV Epidemiologic Update 2015Kathleen Brady Philadelphia HIV Epidemiologic Update 2015
Kathleen Brady Philadelphia HIV Epidemiologic Update 2015
 
Leah Binder Presentation on Leapfrog Group on Maternity Care
Leah Binder Presentation on Leapfrog Group on Maternity CareLeah Binder Presentation on Leapfrog Group on Maternity Care
Leah Binder Presentation on Leapfrog Group on Maternity Care
 
Leah Binder Presentation on Leapfrog Group on Maternity Care
Leah Binder Presentation on Leapfrog Group on Maternity CareLeah Binder Presentation on Leapfrog Group on Maternity Care
Leah Binder Presentation on Leapfrog Group on Maternity Care
 
Mobile Health at Ochsner: The Apple HealthKit and Epic EMR Integration
Mobile Health at Ochsner: The Apple HealthKit and Epic EMR IntegrationMobile Health at Ochsner: The Apple HealthKit and Epic EMR Integration
Mobile Health at Ochsner: The Apple HealthKit and Epic EMR Integration
 
Health2 150416154304-conversion-gate01
Health2 150416154304-conversion-gate01Health2 150416154304-conversion-gate01
Health2 150416154304-conversion-gate01
 
Presentation on the results to date of the Federal Partnership for Patients (...
Presentation on the results to date of the Federal Partnership for Patients (...Presentation on the results to date of the Federal Partnership for Patients (...
Presentation on the results to date of the Federal Partnership for Patients (...
 
Second PPS in the US. Shelly Magill (CDC)
Second PPS in the US. Shelly Magill (CDC)Second PPS in the US. Shelly Magill (CDC)
Second PPS in the US. Shelly Magill (CDC)
 
Survillance and notification of communicable disease
Survillance and notification of communicable diseaseSurvillance and notification of communicable disease
Survillance and notification of communicable disease
 
Central Illinois HIE Summit, Part 2: How HIE Works
Central Illinois HIE Summit, Part 2: How HIE WorksCentral Illinois HIE Summit, Part 2: How HIE Works
Central Illinois HIE Summit, Part 2: How HIE Works
 
Pharmacy Essentials for HIV Screening and Management.2019
Pharmacy Essentials for HIV Screening and Management.2019Pharmacy Essentials for HIV Screening and Management.2019
Pharmacy Essentials for HIV Screening and Management.2019
 
PICOTIn hospitalized medsurg patients , does med reconciliatio.docx
PICOTIn hospitalized medsurg patients , does med reconciliatio.docxPICOTIn hospitalized medsurg patients , does med reconciliatio.docx
PICOTIn hospitalized medsurg patients , does med reconciliatio.docx
 
Hospital treated pneumonia - Diagnosis and Treatment
Hospital treated pneumonia - Diagnosis and TreatmentHospital treated pneumonia - Diagnosis and Treatment
Hospital treated pneumonia - Diagnosis and Treatment
 
Michael Ison - USA -Tuesday 29 - Donor Risk
Michael Ison  - USA -Tuesday 29 - Donor RiskMichael Ison  - USA -Tuesday 29 - Donor Risk
Michael Ison - USA -Tuesday 29 - Donor Risk
 
Day 2: Danielle Rollmann, MIT FoCUS (Nov 19) Access to Innovation Conference ...
Day 2: Danielle Rollmann, MIT FoCUS (Nov 19) Access to Innovation Conference ...Day 2: Danielle Rollmann, MIT FoCUS (Nov 19) Access to Innovation Conference ...
Day 2: Danielle Rollmann, MIT FoCUS (Nov 19) Access to Innovation Conference ...
 
Certified Nurse Leader (CNL) Capstone Project
Certified Nurse Leader (CNL) Capstone ProjectCertified Nurse Leader (CNL) Capstone Project
Certified Nurse Leader (CNL) Capstone Project
 
Story to Sepsis Screen: A Journey in the Details by Elizabeth R. Alpern, MD, ...
Story to Sepsis Screen: A Journey in the Details by Elizabeth R. Alpern, MD, ...Story to Sepsis Screen: A Journey in the Details by Elizabeth R. Alpern, MD, ...
Story to Sepsis Screen: A Journey in the Details by Elizabeth R. Alpern, MD, ...
 
Pediatric Adverse Drug Events Presentation
Pediatric Adverse Drug Events PresentationPediatric Adverse Drug Events Presentation
Pediatric Adverse Drug Events Presentation
 
5.14.11.public health
5.14.11.public health5.14.11.public health
5.14.11.public health
 
5.14.11.public health
5.14.11.public health5.14.11.public health
5.14.11.public health
 

Integration of HIV Testing Within Routine Care in a Large Public Hospital System

  • 1. 1 Integration of HIV Testing Within Routine Care in a Large Public Hospital System Joanna Omi Senior Assistant Vice President Corporate Planning and HIV Services New York City Health and Hospitals Corporation New York, NY November 6, 2007 Copyright 2007, Joanna Omi, Joanna.Omi@nychhc.org
  • 2. 2 Topics covered • Overview of HIV and the HIV Testing Expansion Initiative • Corporatewide and facility results • Lessons learned Copyright 2007, Joanna Omi, Joanna.Omi@nychhc.org
  • 3. 3 8.2 million people live in NYC 100,000 of these are HIV positive and 25,000 do not know it (est.) HHC serves 1.3 million New Yorkers each year It can be extrapolated that each year approximately 4,000 undiagnosed HIV positive New Yorkers access services at an HHC facility HHC is in the epicenter of the national HIV/AIDS epidemic Copyright 2007, Joanna Omi, Joanna.Omi@nychhc.org
  • 4. 4 New York City Health and Hospitals Corporation (HHC) • Public benefit corporation created in 1969 • Largest municipal healthcare delivery system in US – 11 acute care hospitals with State Designated AIDS Centers – 6 diagnostic and treatment centers (D&TCs) – 4 long-term care hospitals – 95 extension clinics – MetroPlus (health maintenance organization) – Partnership in Care (HIV-specific managed care plan) – Home care agency Copyright 2007, Joanna Omi, Joanna.Omi@nychhc.org
  • 5. 5 HHC, continued • 1.3 million New Yorkers served • 224,300 discharges • 4,934,600 visits • $5.5B operating budget • Approximately 19,000 patients with HIV/AIDS Note: FY07 Data Copyright 2007, Joanna Omi, Joanna.Omi@nychhc.org
  • 6. 6 Copyright 2007, Joanna Omi, Joanna.Omi@nychhc.org
  • 7. 7 HIV Testing Expansion Initiative: Integrate HIV testing within routine medical care • Increase the number of patients who know their HIV status • Test 150,000 unique patients (increased from 100,000 in FY06) • Increase the proportion of patients who enter care early • Reduce the number of concurrent AIDS diagnoses • Once in care, retain patients in care • >80% of patients will have 2 medical visits in the last 12 months, with at least one visit in the last 6 months Copyright 2007, Joanna Omi, Joanna.Omi@nychhc.org
  • 8. 8 HIV Testing Expansion Plan Copyright 2007, Joanna Omi, Joanna.Omi@nychhc.org
  • 9. 9 The percentage of unique patients tested at HHC hospitals steadily increased while overall volume remained stable FY05 outpatient and ED Pilot Sites Only (Source: PLM and Pilot Project Sites Reports) FY06-FY07 outpatient, inpatient and ED (Source: PLM and Facility Reports) 3% 6% 7% 5% 7% 7% 5% 7% 10% 5% 4% 6% 5% 7% 9% 9% 9% 11% 11% 11% 10% 9% 7% 9% 8% 14% 13% 17% 12% 13% 15% 18% 15% 16% 8% 13% 0% 2% 4% 6% 8% 1 0% 1 2% 1 4% 1 6% 1 8% 2 0% B ell C IH E lm H ar l Jac K C H L in c M e t N C B Q n s W o od A ll A cu t es %ofvolumetested F Y 05 FY 0 6 F Y 07 Copyright 2007, Joanna Omi, Joanna.Omi@nychhc.org
  • 10. 10 The percentage of unique patients tested at D&TCs steadily increased while overall volume remained stable FY05 outpatient and ED Pilot Sites Only (Source: PLM and Pilot Project Sites Reports) FY06-FY07 outpatient, inpatient and ED (Source: PLM and Facility Reports) 14% 12% 10% 6% 10% 10% 9% 13% 11% 12% 7% 12% 19% 11% 28% 13% 16% 10% 17% 23% 16% 0% 5% 10% 15% 20% 25% 30% B e lv C u m b E N Y G ou v M o rr R en A ll D & T C s %ofvolumetested FY 05 FY 0 6 F Y 07 Copyright 2007, Joanna Omi, Joanna.Omi@nychhc.org
  • 11. 11 9 2,12 3 62 ,023 13 3,8 59 0 30,0 00 60,0 00 90,0 00 1 20,0 00 1 50,0 00 F Y 05 F Y 06 F Y 07 Numberofuniquepatientstested U n iq u e P re n ata l T e st s A ll O th e r U n iq u e T ests The number of unique patients tested grew while prenatal testing remained relatively stable FY05 All other unique tests outpatient and ED Pilot Sites Only (Source: PLM and Pilot Project Sites Reports) FY06-FY07 All other unique tests outpatient, inpatient and ED (Source: Facility Reports) FY05-FY07 Unique prenatal tests prenatal clinics only (Source: Siemens Data Warehouse) 45.3% 48.5% Copyright 2007, Joanna Omi, Joanna.Omi@nychhc.org
  • 12. 12 Rapid HIV testing comprised the majority of unique tests conducted in FY06 and FY07 FY05 outpatient and ED Pilot Sites Only (Source: PLM and Pilot Project Sites Reports) FY06-FY07 outpatient, inpatient and ED (Source: Facility Reports) 0 5,000 10,000 15,000 20,000 25,000 30,000 35,000 40,000 Q1 Q 2 Q 3 Q 4 Q 1 Q2 Q 3 Q 4 Q 1 Q2 Q3 Q 4 NumberofUniquePatientsTested C on vention al R H T FY 05 FY 06 FY 0 7 Copyright 2007, Joanna Omi, Joanna.Omi@nychhc.org
  • 13. 13 But the use of rapid testing varied widely across facilities FY07 outpatient, inpatient and ED (Source: Facility Reports) 74% 100% 96% 99% 59% 100% 68% 100% 98% 35% 99% 90% 64% 99% 73% 95% 91% 26% 0% 4% 1% 41% 0% 32% 0% 2% 65% 1% 10% 36% 1% 27% 5% 9% 0% 20% 40% 60% 80% 100% Bell Belv CIH Cumb Elm ENY Gouv Harl Jac KCH L inc M et M orr NC B Qns R enn Wood %oftotaltestsbytechnology RHT Conv Copyright 2007, Joanna Omi, Joanna.Omi@nychhc.org
  • 14. 14 Patients in Care, Prevalence, Incidence and Venues Copyright 2007, Joanna Omi, Joanna.Omi@nychhc.org
  • 15. 15 People of color continue to represent the largest percentage of unique HIV positive patients in care… FY06-FY07 All Venues (Source: PLM Database) 5%5 % 3 5% 53 % 1 % 5%4% 35% 54 % 1% 0 2,00 0 4,00 0 6,00 0 8,00 0 1 0,00 0 1 2,00 0 1 4,00 0 1 6,00 0 1 8,00 0 2 0,00 0 A S IA N B L A C K H IS P A N IC O T H E R W H IT E G r an d T ota l HIVpatientsincarebyrace FY 06 A ll V en u es FY 07 A ll V en u es 100 %10 0% Copyright 2007, Joanna Omi, Joanna.Omi@nychhc.org
  • 16. 16 While men continue to represent the largest number of unique HIV positive patients in care FY06-FY07 All Venues (Source: PLM Database) 6 1 % 3 9 % 6 1 % 3 9 % 0 2 ,0 0 0 4 ,0 0 0 6 ,0 0 0 8 ,0 0 0 1 0 ,0 0 0 1 2 ,0 0 0 1 4 ,0 0 0 1 6 ,0 0 0 1 8 ,0 0 0 2 0 ,0 0 0 F E M A L E M A L E G ra n d T o ta l HIVpatientsincarebysex F Y 0 6 A ll V en u es F Y 0 7 A ll V en u es 1 0 0 %1 0 0 % Copyright 2007, Joanna Omi, Joanna.Omi@nychhc.org
  • 17. 17 Both the total number of unique patients who tested HIV positive and the subgroup newly diagnosed with HIV increased in FY07 FY06-FY07 outpatient, inpatient and ED (Source: Facility Reports) 1,514 774 1,630 8 64 0 20 0 40 0 60 0 80 0 1,00 0 1,20 0 1,40 0 1,60 0 1,80 0 All Pa tients w /HIV Po sitive R esults New ly Dia gnosed HIV Po sitiv e Pa tients FY06 FY07 TotalHIVpositiveandnewlydiagnosed 8% 12% Copyright 2007, Joanna Omi, Joanna.Omi@nychhc.org
  • 18. 18 Most networks focused their expansion efforts in the outpatient and ED areas FY07 outpatient, inpatient and ED (Source: Facility Reports) 87% 66% 74% 68% 54% 78% 71% 69% 9% 9% 4% 8% 7% 4% 12% 8% 4% 25% 21% 25% 39% 19% 18% 24% 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% C. Bkln Gen + N. Brx N. Bkln Qns S. Bkln S. Man. Corp. %oftotaltestsbyvenue Outpatient Inpatient ED Copyright 2007, Joanna Omi, Joanna.Omi@nychhc.org
  • 19. 19 Across all networks, prevalence was highest in inpatient units FY07 outpatient, inpatient and ED (Source: Facility Reports) 1% 1% 1 % 2% 1% 0 % 2% 1% 6% 3% 6 % 4% 3% 4 % 5% 4% 4 % 1% 1% 1 % 1% 1% 2 % 1% 0 % 1 % 2 % 3 % 4 % 5 % 6 % 7 % C. Bkln G en + N . Brx N. Bkln Qns S. Bkln S . M an. C orp. HIVprevalencebyvenue OP IP ED Copyright 2007, Joanna Omi, Joanna.Omi@nychhc.org
  • 20. 20 As was the percentage of newly diagnosed HIV positive patients FY07 outpatient, inpatient and ED (Source: Facility Reports) 0 .6% 0.4 % 0.3% 0 .6% 0.4 % 0.3% 0 .6% 0.5 % 4 % 1% 3% 2 % 2% 4 % 2% 2% 2.2% 0 .9% 0.8 % 1.1% 0.4% 0.5 % 0 .9% 0.8% 0% 1% 2% 3% 4% 5% C. Bkln G en + N . Brx N. Bkln Qns S. Bkln S . M an. C orp. HIVPrevalencebyvenue OP IP ED Copyright 2007, Joanna Omi, Joanna.Omi@nychhc.org
  • 21. 21 Preliminary utilization data suggest the proportion of newly HIV positive individuals may be greater in HHC than in the city as a whole FY07 outpatient, inpatient and ED (Source: Facility Reports) NYC Incidence (Source: NYCDOHMH HIV Incidence Estimates Using STARHS – the serologic testing algorithm for recent HIV seroconversions. CROI poster 2/2007) NYC Prevalence (Source: NYC HIV/AIDS Annual Surveillance Statistics. 12/2006) HHC Incidence 0.76%0.45% 2.02% 0% 1% 2% 3% 4% Outpatient Inpatient ED HHC Prevalence 3.78% 0.98% 1.08% 0% 1% 2% 3% 4% Outpatient Inpatient ED HHC Prevalence = 1.22% NYC Prevalence=1.2% HHC Incidence = .65% NYC Incidence = .31% Copyright 2007, Joanna Omi, Joanna.Omi@nychhc.org
  • 22. 22 Patients newly diagnosed with HIV in outpatient areas are more likely to be scheduled for and keep their first HIV primary care appointment FY07 outpatient, inpatient and ED (Source: Facility Reports) 94 % 6 8% 85 % 86 % 90 % 77% 7 9% 84 % 0 % 20 % 40 % 60 % 80 % 1 00 % O utpatie nt Inpa tien t ED To tal %ofnewlydxpatientsscheduledandkeepingappointment A p poin tm en t M a de A ppo intm e nt K e pt Copyright 2007, Joanna Omi, Joanna.Omi@nychhc.org
  • 23. 23 Of patients newly diagnosed with HIV who kept their first HIV appointment, fewer were concurrently diagnosed with AIDS in FY07 vs. FY06 FY06-FY07 outpatient, inpatient and ED (Source: Facility Reports) 25 % 54 % 3 6% 32 % 1 6% 32 % 2 3% 21 % 0% 1 0% 2 0% 3 0% 4 0% 5 0% 6 0% O u tp atie n t I n p a tien t E D T o tal F Y 06 F Y 07 ProportionofNewHIVdxconcurrentlydxAIDSbyvenue Copyright 2007, Joanna Omi, Joanna.Omi@nychhc.org
  • 24. 24 Accomplishments • Large-scale implementation led to the identification of a significant number of individuals who would not likely otherwise have taken the opportunity to test. • Rapid HIV testing is now available at all HHC acute care hospitals and D&TCs (17 sites). • All HHC acute care hospitals now offer HIV testing in multiple venues: ED, inpatient units and at least three outpatient clinics (including Dental, Medicine, Women’s Health Services, Adolescent Health Services and Chemical Dependency). Copyright 2007, Joanna Omi, Joanna.Omi@nychhc.org
  • 25. 25 Variables that impact the expansion of testing across HHC Drivers – Widespread use of a rapid, easy-to-use HIV test – Consistent use of the streamlined HIV counseling model with regular monitoring and evaluation – Clinical and executive level commitment to expand testing within the facilities Inhibitors – Number of clinicians offering and conducting testing at some facilities – Availability of interdisciplinary teams 24/7 – Dedicated space for counseling HIV-positive patients in all venues Copyright 2007, Joanna Omi, Joanna.Omi@nychhc.org
  • 26. 26 Data Caveats • FY05 testing data represents outpatient and ED Pilot Sites only. • Data for FY06 and FY07 HIV-positive patients in care reflects patients connected to care at the time of report and does not capture patients who may have entered care at a later date. • The number of unique patients tested for HIV is based on patient self-report and facility medical records. • Identification of ‘new diagnosis’ is based on patient self-report and facility medical records. • Medical records are unique to each facility and in some cases, networks. It is possible in some instances that counts are not unduplicated between sites. Copyright 2007, Joanna Omi, Joanna.Omi@nychhc.org
  • 27. 27 Summary messages • Encouraging patients to know their HIV status is a message that resonates with health care professionals. • The presence of clinician champions and well functioning, interdisciplinary teams can significantly improve testing rates. • Inpatient testing provides significant opportunities as well as challenges in complex teaching facilities. • Best practices for successful expansion of HIV testing will look different at each facility – one size does not fit all. • HHC - facilities and centrally - will continue to examine the data being generated to inform long-term direction and other service and policy implications. Copyright 2007, Joanna Omi, Joanna.Omi@nychhc.org
  • 28. 28 Acknowledgements and Appreciation Terry Hamilton, Director of HIV Services, HHC Drew De Los Reyes, Senior Management Consultant, HHC Jay Gabor, Senior Management Consultant, HHC Judy Aberg, MD, Medical Director of HIV Services, Bellevue Hospital Center and the HHC South Manhattan Network The dedicated physicians, nurses, administrators, patient care associates, HIV counselors, phlebotomists, lab directors and many others throughout HHC who have contributed to the HIV testing expansion effort Copyright 2007, Joanna Omi, Joanna.Omi@nychhc.org